Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
about
Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease modelsMetabotropic glutamate receptors in the basal ganglia motor circuitMetabotropic glutamate receptors: from the workbench to the bedside.Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brainCortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.Therapeutic potential of metabotropic glutamate receptor modulators.Liquid chromatographic-electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain.Glutamate receptors as therapeutic targets for Parkinson's disease.The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's diseaseTargeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.Therapeutic potential of targeting glutamate receptors in Parkinson's disease.Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons.Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.
P2860
Q24673667-70809D5C-11C5-4A15-A78C-D8FF079A5A06Q28280931-DFAF654F-0828-4D57-A264-9D3637385217Q30448778-BD0B6BF8-1D80-4DED-89EB-F4975EC5E5B8Q30492449-93B26DBB-94D2-456B-AAF7-60C2D9142300Q33492743-6155FCA3-61AF-4EF8-8FD3-33864F63BB86Q33594065-7048B7B7-6D74-4340-82E2-40487838FD4BQ34116613-4317DA4B-D960-471E-96CD-EAE2F06682C5Q34296136-C931AC63-E880-4A9A-8374-C8C3824B48B3Q34725251-6AF64180-6A58-4DDE-B77E-CD8C9935C14FQ35778704-E88D035B-1B03-4EA5-936F-0D8FE3FFAA7CQ35997651-3679C9BD-B5E6-41D7-88B8-80517389B823Q37585401-145DBE12-F692-44E8-8F2C-4067DABAF841Q37845675-B318AA1F-E190-4CA9-B9F9-A7938A4F6ECAQ38056852-FB4F969D-1FC9-41CC-8077-FC8A61F1C84BQ38092819-0E5EC611-793F-444C-AF23-56366DC39FDBQ38174986-9A6E3A3C-4B95-498B-B4BF-FE635AEEAE46Q38190016-E23C308C-2EBC-433B-B67F-59637A09FD6CQ39101398-EC95C7BC-7A20-4DC6-A519-71A5114419A7Q41774971-C430E8F7-07E6-4239-BF6C-27DD8A61072BQ52665081-B82B0AB3-D8C2-42DD-84CB-A3612EE76EB8
P2860
Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@en
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@nl
type
label
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@en
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@nl
prefLabel
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@en
Protective role of group-II me ...... ,6-tetrahydropyridine in mice.
@nl
P2093
P50
P1433
P1476
Protective role of group-II me ...... 3,6-tetrahydropyridine in mice
@en
P2093
Antonio Paparelli
Fabrizio Pontarelli
Stefano Ruggieri
P304
P356
10.1016/S0028-3908(03)00146-1
P577
2003-08-01T00:00:00Z